申请人:Celltech R & D, Inc.
公开号:US20020187984A1
公开(公告)日:2002-12-12
The synthesis of novel diketopiperazines, their use in inhibiting cellular events such as those involving NFK-&agr;, NFK-&bgr; and in the treatment of inflammation events, a combinatorial library of diverse diketopiperazines and process for their synthesis as a library and as individual compounds. In particular novel diketopiperazines are disclosed including their synthesis and use in cellular events such as activation of the transcription factor, nuclear factor, TNF-&agr;, TNF-&bgr; and also apoptosis.
合成新型二酮肽、它们在抑制细胞事件中的应用,如涉及NFK-α、NFK-β和治疗炎症事件,多样化二酮肽组合库及其作为库和单个化合物的合成过程。特别是披露了新型二酮肽,包括它们的合成和在细胞事件中的应用,如转录因子、核因子、TNF-α、TNF-β的激活以及凋亡。